61314-304 : Zarxio 300 ug/.5ml Intravenous; Subcutaneous Injection, Solution


NDC61314-304
Labeler: Sandoz Inc
Product Type: Human Prescription Drug
Drug Name:  Zarxio
Dosage Form: Intravenous; Subcutaneous Injection, Solution
Application #: BLA125553
Rev. Date: 


NDC Package Codes:

  • 61314-304-01: 1 BLISTER PACK IN 1 CARTON (61314‑304‑01) > 1 SYRINGE IN 1 BLISTER PACK > .5 ML IN 1 SYRINGE
  • 61314-304-10: 2 BLISTER PACK IN 1 CARTON (61314‑304‑10) > 5 SYRINGE IN 1 BLISTER PACK > .5 ML IN 1 SYRINGE

Active Ingredients:

  • Filgrastim
  • License Holder Unspecified

Dosage Strength:

  • 300 ug/.5mL

Pharmaceutical Classes:

  • Granulocyte Colony-Stimulating Factor [CS]
  • Granulocyte-Macrophage Colony-Stimulating Factor [CS]
  • Increased Myeloid Cell Production [PE]
  • Leukocyte Growth Factor [EPC]

Related Products:

Based on records with the same trade name.
  • 61314-312 Zarxio 480 ug/.8ml Intravenous; Subcutaneous Injection, Solution by Sandoz Inc
  • 61314-318 Zarxio 300 ug/.5ml Intravenous; Subcutaneous Injection, Solution by Sandoz Inc.
  • 61314-326 Zarxio 480 ug/.8ml Intravenous; Subcutaneous Injection, Solution by Sandoz Inc.

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 61314-304 QR Code

< Prev: 61314-303Next: 61314-308 >




Notice: The MedsChat® NDC Database compiles publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.


Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 7 August 2015.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA